Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Nuclear Medicine

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 15181136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FDG Uptake , GLUT-i Glucose Transporterand Cellularity in Human Pancreatic Tumors

  2006cited by this paper
• Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

  2001cited by this paper
• Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET

  2001cited by this paper
• Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.

  2001cited by this paper
• Trends in the prevalence of infection with mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models.

  2000cited by this paper
• Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia

  2000cited by this paper
• Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

  2000cited by this paper
• Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

  1999cited by this paper
• 비소세포폐암 환자의 국소 림프절 전이 발견을 위한 FDG PET의 이용

  1999cited by this paper
• Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.

  1998cited by this paper
• FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.

  1998cited by this paper
• PET in oncology: will it replace the other modalities?

  1997cited by this paper
• Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival

  1997cited by this paper
• Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

  1997cited by this paper
• Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.

  1996cited by this paper
• Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

  1996cited by this paper
• GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.

  1995cited by this paper
• Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?

  1995cited by this paper
• Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.

  1994cited by this paper
• Facilitative glucose transporters.

  1994cited by this paper
• Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.

  1994cited by this paper
• Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose

  1994cited by this paper
• Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

  1993cited by this paper
• Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

  1992cited by this paper
• Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody.

  1987cited by this paper
• Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result.

  1979cited by this paper
• Enzymology of cancer cells (second of two parts).

  1977cited by this paper

• Prevalence of GLUT1 overexpression in human cancers a systematic review and meta analysis

  2025cites this paper
• Motion-resolved parametric imaging derived from short dynamic [18F]FDG PET/CT scans.

  2025cites this paper
• Comparison of diagnostic value of quantitative parameters from FAPI and FDG PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer

  2024cites this paper
• Pitfalls on 18‐fluorodeoxyglucose positron emission tomography‐computed tomography: Immunoglobulin G4‐related lymphadenopathy

  2024cites this paper
• The diagnostic value of 68Ga-NOTA-MAL-Cys-MZHER2:342 PET/CT imaging for HER2-positive lung adenocarcinoma

  2024cites this paper
• Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?

  2024cites this paper
• Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review

  2024cites this paper
• The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma

  2023cites this paper
• Multidisciplinary Postoperative Validation of 18F-FDG PET/CT Scan in Nodal Staging of Resected Non-Small Cell Lung Cancer

  2022cites this paper
• Assessment of intrathoracic lymph nodes by FDG PET/CT in patients with asbestos-related lung cancer

  2021cites this paper
• 18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor

  2021cites this paper
• The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non–small cell lung cancer

  2021cites this paper
• 18F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer

  2019cites this paper
• Targeting uptake transporters for cancer imaging and treatment

  2019cites this paper
• GLUT1: A novel tool reflecting proliferative activity of lung neuroendocrine tumors?

  2017cites this paper
• Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.

  2017cites this paper
• Diagnosing giant cell tumor of the bone using positron emission tomography/computed tomography: A retrospective study of 20 patients from a single center

  2017cites this paper
• Perspectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy

  2016cites this paper
• Interactive Communication Between PET Specialists and Oncologists

  2016cites this paper
• Unusual False-Positive Mesenteric Lymph Nodes Detected by PET/CT in a Metastatic Survey of Lung Cancer

  2016cites this paper
• GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography

  2016cites this paper
• Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

  2015influential citation
• 18FDG synthesis and supply: a journey from existing centralized to future decentralized models.

  2015cites this paper
• Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC)

  2015influential citation
• MINI-REVIEW 18 FDG Synthesis and Supply: a Journey from Existing Centralized to Future Decentralized Models

  2014cites this paper
• Tenosynovial Giant Cell Tumor of Diffuse Type Mimicking Bony Metastasis Detected on F-18 FDG PET/CT

  2014cites this paper
• Reactive Tonsillar Enlargement Showing Strong 18F-Fdg Uptake During the Follow-Up of Follicular Lymphoma

  2013cites this paper
• Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.

  2013cites this paper
• Erratum to: Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging

  2013cites this paper
• Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging

  2013cites this paper
• Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography–computed tomography (PET/CT)

  2013cites this paper
• Heterogeneity Analysis of 18F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting

  2013cites this paper
• Passive fructose transporters in disease: a molecular overview of their structural specificity.

  2013cites this paper
• Flow synthesis of a versatile fructosamine mimic and quenching studies of a fructose transport probe

  2013cites this paper
• The Role of 18F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma

  2012cites this paper
• Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.

  2012cites this paper
• Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.

  2012cites this paper
• Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.

  2012cites this paper
• F-18 FDG PET/CT imaging of follicular dendritic cell sarcoma of the mediastinum.

  2012cites this paper
• Pattern and Predictors of False Positive Lymph Node Involvement on Positron Emission Tomography in Patients with Non-Small Cell Lung Cancer

  2011cites this paper
• Ralstonia mannitolilytica and COPD: a case report

  2011cites this paper
• PET/CT Imaging

  2011cites this paper
• Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.

  2011cites this paper
• EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism

  2011cites this paper
• Impact of Lymphoid Follicles and Histiocytes on the False-Positive FDG Uptake of Lymph Nodes in Non-Small Cell Lung Cancer

  2011cites this paper
• A systemic review of PET and biology in lung cancer.

  2011cites this paper
• Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting.

  2011cites this paper
• Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer

  2010cites this paper
• Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

  2010cites this paper
• Prognostic and predictive factors in resected non-small-cell lung cancer.

  2010cites this paper
• Mediastinal and aortic disease

  2010cites this paper
• Biologic Correlation of 2-( 18 F)-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography in Thymic

  2010cites this paper
• Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis

  2010cites this paper
• Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer.

  2010cites this paper
• Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer.

  2009cites this paper
• 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization*

  2009cites this paper
• Differential Expression of Glut 1 in Pulmonary Neuroendocrine Tumors : Correlation with Histological Grade Corresponding

  2009cites this paper
• Differential Expression of Glut1 in Pulmonary Neuroendocrine Tumors: Correlation with Histological Grade

  2009cites this paper
• Continuing Education for Nuclear Pharmacists and Nuclear Medicine Professionals

  2009cites this paper
• Evaluation of thoracic tumors with 18F‐FMT and 18F‐FDG PET‐CT: A clinicopathological study

  2009cites this paper
• 18F-FDG and 18F-FLT Do Not Discriminate Between Reactive and Metastatic Lymph Nodes in Oral Cancer

  2009cites this paper
• Differential diagnosis between 18F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan

  2009cites this paper
• Benign F-18 FDG uptake along a mediastinoscopy tract: demonstration by F-18 FDG PET/CT imaging.

  2008cites this paper
• High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.

  2008cites this paper
• Non-small Cell Lung Cancer: False-positive Results with 18F-fluorodeoxyglucose Positron Emission Tomography

  2008cites this paper
• Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer

  2008cites this paper
• 18F-FDG Uptake in Reactive Neck Lymph Nodes of Oral Cancer: Relationship to Lymphoid Follicles

  2008cites this paper
• Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.

  2008cites this paper
• FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.

  2007cites this paper
• Meckel's diverticulum--an incidental finding on PET/CT.

  2007cites this paper
• Institutional report - Thoracic general Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography

  2007cites this paper
• Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study

  2007cites this paper
• Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography.

  2007cites this paper
• Biological correlates of FDG uptake in non-small cell lung cancer.

  2007cites this paper
• Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro.

  2007cites this paper
• Consideration of serum glucose levels during malignant mediastinal lymph node detection in non‐small‐cell lung cancer by FDG‐PET

  2006cites this paper
• In vitro studies on the signal transduction of thyroidal uptake of 18F-FDG and 131I-Iodide.

  2006cites this paper
• FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.

  2006cites this paper
• False-Positive FDG PET Uptake−the Role of PET/CT

  2006cites this paper
• Pitfalls in Integrated CT-PET of the Thorax: Implications in Oncologic Imaging

  2006cites this paper
• Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer

  2006cites this paper
• GLUT1 expression in tissue and (18)F-FDG uptake.

  2004cites this paper